DrugPatentWatch Database Preview

Janssen Prods Company Profile

« Back to Dashboard

What is the competitive landscape for JANSSEN PRODS, and when can generic versions of JANSSEN PRODS drugs launch?

JANSSEN PRODS has seven approved drugs.

There are thirty-three US patents protecting JANSSEN PRODS drugs.

There are nine hundred and thirty patent family members on JANSSEN PRODS drugs in sixty-seven countries and one hundred and seventy supplementary protection certificates in sixteen countries.

Summary for Janssen Prods

International Patents:	930
US Patents:	33
Tradenames:	6
Ingredients:	6
NDAs:	7

Drugs and US Patents for Janssen Prods

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Prods	SYMTUZA	cobicistat; darunavir ethanolate; emtricitabine; tenofovir alafenamide fumarate	TABLET;ORAL	210455-001	Jul 17, 2018		RX	Yes	Yes	7,700,645		Y	Y
Janssen Prods	EDURANT	rilpivirine hydrochloride	TABLET;ORAL	202022-001	May 20, 2011		RX	Yes	Yes	7,067,522		Y	Y
Janssen Prods	EDURANT	rilpivirine hydrochloride	TABLET;ORAL	202022-001	May 20, 2011		RX	Yes	Yes	6,838,464		Y	Y
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006		DISCN	Yes	No	8,518,987*PED				Y

Expired US Patents for Janssen Prods

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	6,037,157*PED
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	RE42889*PED
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-006	Nov 9, 2012	6,248,775*PED
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	5,583,131

Paragraph IV (Patent) Challenges for JANSSEN PRODS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	800 mg		2013-05-14

International Patents for Janssen Prods Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	2937339
Poland	360490
Spain	2603617
Lithuania	2682397

Supplementary Protection Certificates for Janssen Prods Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1663240	58/2015	Austria		PRODUCT NAME: KOMBINATION VON RILPIVIRIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ VON RILPIVIRIN, EINSCHLIESSLICH DES HYDROCHLORIDSALZES VON RILPIVIRIN, UND EMTRICITABIN; REGISTRATION NO/DATE: EU/1/11/737/001-002 20111128
1632232	PA2016042	Lithuania		PRODUCT NAME: RILPIVIRINO HIDROCHLORIDAS + EMTRICITABINAS + TENOFOVIRO ALAFENAMIDAS; REGISTRATION NO/DATE: EU/1/16/1112 20160621
0513200	SPC/GB04/016	United Kingdom		PRODUCT NAME: EMTRICITABINE OR SALTS AND ESTERS THEREOF; REGISTERED: UK EU/1/03/261/001 20031024; UK EU/1/03/261/002 20031024; UK EU/1/03/261/003 20031024
1663240	60/2015	Austria		PRODUCT NAME: KOMBINATION VON RILPIVIRIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ VON RILPIVIRIN, EINSCHLIESSLICH DES HYDROCHLORIDSALZES VON RILPIVIRIN, UND TENOFOVIR, INSBESONDERE TENOFOVIRDISOPROXILFUMARAT; REGISTRATION NO/DATE: EU/1/11/737/001-002 20111128

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Janssen Biotech
• Janssen Pharma
• Janssen Pharms
• Janssen Prods